Background: With the aim of developing a monkey model of HIV-1 infection, we have been utilizing a combination of macaque-tropic HIV-1 (HIV-1mt) and cynomolgus macaques (CM). While we previously reported that CXCR4-tropic HIV-1mt (X4 virus) replicated efficiently in CM homozygous for TRIMCyp, none of infected animals had persistent viremia. Since most HIV-1 in human population use CCR5 as a co-receptor (R5 virus) during transmission, the coreceptor usage may be important for establishment of persistent infection in monkeys. Based on this hypothesis, we here constructed an R5-tropic HIV-1mt and analyzed viral replication in monkeys.
Methodology: The 5’ region (from 5’ LTR to vpu ) and 3’ region (from env to 3’ LTR) of viral genome were PCR amplified from X4-tropic HIV-1mt plasmid with high fidelity DNA polymerase. By overlapping with these fragments, a fragment covering env gene was PCR amplified from an R5-SHIV MK38 strain that shows pathogenicity in infected rhesus macaques. These amplified fragments were subjected to co-transfection of stably CCR5 expressing T cell line, C8166-CCR5 cells. Several days after co-transfection, an R5-tropic HIV-1mt named MN38 strain was collected. We analyzed the co-receptor usage of MN38 and monitored its replication capability in CM PBMCs. We further analyzed the replication property of MN38 in monkeys having TRIMCyp.
Results: MN38 virus showed CCR5-tropism and replicated well in CM PBMCs. In monkeys, MN38 induced viremia, with plasma viral loads reaching a peak at 2-3 weeks post infection and ranging from 1.5×104 to 1.0×105 copies/ml. While the viremia became undetectable at 8 weeks post infection, administration of anti-CD8 monoclonal antibody into animals led to reappearance of viremia. In order to obtain monkey-adapted virus, we then inoculated plasma and whole blood of MN38-infected animals into one naive monkey. The inoculated virus stock was named MN38P1. MN38P1 replicated well in the recipient monkey and established persistent viremia. We further performed the 2nd round of adaptation. The virus stock named MN38P2 was inoculated into two naive CM. We observed an increase in levels of acute viremia, reaching 106 copies/ml in these animals.
Conclusions: We successfully obtained a monkey-adapted R5-HIV-1mt strain. This virus was found to induce persistent viremia in CM for at least 20 weeks. This combination of MN38-ralated strains and CM will encourage us to develop pre-clinical animal model of HIV-1 infection. We are still following up on the possibility of establishment of long-term persist infection. Moreover, it will be of great interest to elucidate which viral mutations are responsible for adaptation in monkeys. To this end, we are now analyzing whole viral genome by using next generation sequencing method.